Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

TriPath Imaging Inc.

BioPhotonics
Jun 2006
TriPath Imaging Inc. of Burlington, N.C., has received the FDA’s 510(k) approval to use the Ki-67 cell proliferation biomarker with the Ventana Image Analysis System from Ventana Medical Systems Inc. of Tucson, Ariz. The biomarker enables pathologists to determine the percentage of tumor cells that are actively dividing with precise quantitative measurements of the biomarker’s expression in breast biopsy samples. The approach is expected to aid scientists in further investigations into the correlation between proliferation rate and survival.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!